L. Mitchell

发表

Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.

S. Caruthers, D. Hourcade, D. Pan, 2015, Nanomedicine : nanotechnology, biology, and medicine.

Novo Convertase Assembly Surfaces and Providing a Platform for De Activation by Binding Specific Target Properdin Can Initiate Complement

D. Hourcade, J. Atkinson, D. Spitzer, 2007 .

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2

Gregory F. Wu, S. Whelan, D. Perantie, 2021, Annals of Internal Medicine.

The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis

D. Hourcade, Lijuan Zhang, C. Kemper, 2008, Proceedings of the National Academy of Sciences.

Detection of complement activation using monoclonal antibodies against C3d.

Bärbel Rohrer, Dennis E Hourcade, J. Thurman, 2013, The Journal of clinical investigation.

Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2

Gregory F. Wu, S. Whelan, D. Perantie, 2021, medRxiv.

A Corresponding Tyrosine Residue in the C2/Factor B Type A Domain Is a Hot Spot in the Decay Acceleration of the Complement C3 Convertases*

D. Hourcade, J. Atkinson, L. Kuttner-Kondo, 2003, Journal of Biological Chemistry.

Decay-accelerating Factor (DAF), Complement Receptor 1 (CR1), and Factor H Dissociate the Complement AP C3 Convertase (C3bBb) via Sites on the Type A Domain of Bb*

D. Hourcade, J. Atkinson, L. Kuttner-Kondo, 2002, The Journal of Biological Chemistry.

Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases*

D. Hourcade, D. Soares, P. Barlow, 2007, Journal of Biological Chemistry.

Characterization of the Active Sites in Decay-Accelerating Factor1

D. Hourcade, L. Kuttner-Kondo, L. Mitchell, 2001, The Journal of Immunology.

Decay-Accelerating Factor Characterization of the Active Sites in and

D. Hourcade, L. Kuttner-Kondo, L. Mitchell, 2001 .

Decay acceleration of the complement alternative pathway C3 convertase.

D. Hourcade, L. Mitchell, M. Medof, 1999, Immunopharmacology.

Anti-complement activity of the Ixodes scapularis salivary protein Salp20.

D. Hourcade, C. Pham, A. Akk, 2016, Molecular immunology.

Properdin Can Initiate Complement Activation by Binding Specific Target Surfaces and Providing a Platform for De Novo Convertase Assembly1

D. Hourcade, J. Atkinson, D. Spitzer, 2007, The Journal of Immunology.

Properdin: Cell Death's Little Helper?

D. Hourcade, C. Kemper, L. Mitchell, 2007 .

Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis

S. Heck, T. Woodruff, D. Hourcade, 2020, Cellular & Molecular Immunology.

A Conserved Element in the Serine Protease Domain of Complement Factor B*

D. Hourcade, T. Oglesby, L. Mitchell, 1998, The Journal of Biological Chemistry.

Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding.

D. Hourcade, T. Oglesby, L. Mitchell, 1999, Journal of immunology.

Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces*

Samuel A Wickline, Gregory M Lanza, Dipanjan Pan, 2010, The Journal of Biological Chemistry.

High-Affinity C3b-Binding Complement Factor B That Promote Mutations of the Type A Domain of

D. Hourcade, L. Mitchell, J. Teresa, 2013 .

High-Affinity C 3 b-Binding Complement Factor B That Promote Mutations of the Type A Domain of Oglesby

D. Hourcade, L. Mitchell, Lynne M. Mitchell, 1999 .

A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.

J. Thurman, D. Hourcade, G. Gilkeson, 2005, Molecular immunology.

Access to the Complement Factor B Scissile Bond Is Facilitated by Association of Factor B with C3b Protein*

D. Hourcade, L. Mitchell, 2011, The Journal of Biological Chemistry.

Title: Deep-phenotyping detects a pathological CD4 + T cell complosome signature in 1 systemic sclerosis 2 Running Title: A novel pathogenic T cell signature in scleroderma

Nocerino, S. Heck, T. Woodruff, 2019 .

A Monoclonal Antibody That Provides a Model for C3 Nephritic Factors.

D. Hourcade, L. Mitchell, 2023, Monoclonal antibodies in immunodiagnosis and immunotherapy.

Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.

Nathan A. Baker, Nathan A Baker, Gregory M Lanza, 2014, Nanomedicine : nanotechnology, biology, and medicine.

The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis

D. Hourcade, Lijuan Zhang, C. Kemper, 2008, Proceedings of the National Academy of Sciences.

Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces*

D. Hourcade, S. Wickline, G. Lanza, 2010, The Journal of Biological Chemistry.